Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Albertelli

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Pharmaceuticals (Basel, Switzerland)|April 26, 2025
Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective EvaluationLaura Musso, Cristina Maltese, Giulio Beretta, et al.
Neuroendocrinology|October 19, 2020
Efficacy of a Novel Second-Generation Somatostatin-Dopamine Chimera (TBR-065) in Human Medullary Thyroid Cancer: A Preclinical StudyAlessandra Dicitore, Maria Celeste Cantone, Germano Gaudenzi, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 28, 2005
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferationDiego Ferone, Marica Arvigo, Claudia Semino, et al.
NPJ Digital Medicine|December 23, 2025
ARTEMIS: a pilot study comparing AI-based and expert therapeutic decisions in simulated clinical cases of neuroendocrine neoplasmsGiuseppe Lamberti, Francesco Panzuto, Sara Massironi, et al.
Endocrine|March 28, 2015
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre studyDavide Campana, Davide Ravizza, Piero Ferolla, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2009
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetesCecilia Marini, GianPaolo Bezante, Patrizia Gandolfo, et al.
Journal of Clinical Medicine|November 11, 2022
Trabecular Bone Score as a Reliable Measure of Lumbar Spine Bone Microarchitecture in Acromegalic PatientsElena Nazzari, Andrea Casabella, Sabrina Paolino, et al.
Minerva Endocrinology|June 16, 2023
Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assaysAntongiulio Faggiano, Elisa Giannetta, Roberta Modica, et al.
Journal of Endocrinological Investigation|April 28, 2025
Diabetes mellitus secondary to endocrine diseases: a position statement of the working group of the club of the Italian society of endocrinology (SIE)-Nutrition hormones and metabolismLuigi Barrea, Massimiliano Caprio, Sebastio Perrini, et al.
Journal of Neuroendocrinology|July 16, 2021
Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging noveltiesKetevani Kankava, Patrick Maisonneuve, Alessandro Mangogna, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Pharmaceuticals (Basel, Switzerland)|April 26, 2025
Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective EvaluationLaura Musso, Cristina Maltese, Giulio Beretta, et al.
Neuroendocrinology|October 19, 2020
Efficacy of a Novel Second-Generation Somatostatin-Dopamine Chimera (TBR-065) in Human Medullary Thyroid Cancer: A Preclinical StudyAlessandra Dicitore, Maria Celeste Cantone, Germano Gaudenzi, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 28, 2005
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferationDiego Ferone, Marica Arvigo, Claudia Semino, et al.
NPJ Digital Medicine|December 23, 2025
ARTEMIS: a pilot study comparing AI-based and expert therapeutic decisions in simulated clinical cases of neuroendocrine neoplasmsGiuseppe Lamberti, Francesco Panzuto, Sara Massironi, et al.
Endocrine|March 28, 2015
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre studyDavide Campana, Davide Ravizza, Piero Ferolla, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2009
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetesCecilia Marini, GianPaolo Bezante, Patrizia Gandolfo, et al.
Journal of Clinical Medicine|November 11, 2022
Trabecular Bone Score as a Reliable Measure of Lumbar Spine Bone Microarchitecture in Acromegalic PatientsElena Nazzari, Andrea Casabella, Sabrina Paolino, et al.
Minerva Endocrinology|June 16, 2023
Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assaysAntongiulio Faggiano, Elisa Giannetta, Roberta Modica, et al.
Journal of Endocrinological Investigation|April 28, 2025
Diabetes mellitus secondary to endocrine diseases: a position statement of the working group of the club of the Italian society of endocrinology (SIE)-Nutrition hormones and metabolismLuigi Barrea, Massimiliano Caprio, Sebastio Perrini, et al.
Journal of Neuroendocrinology|July 16, 2021
Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging noveltiesKetevani Kankava, Patrick Maisonneuve, Alessandro Mangogna, et al.
Pageof 7